查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466372

切片檢查設備市場：按產品、技術、應用和最終用戶分類 - 全球預測 2024-2030

Biopsy Devices Market by Product (Biopsy Forceps, Localization Wires, Needle-Based Biopsy Instruments), Technique (Image Guided Biopsy, Non-Image Guided Biopsy), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

切片檢查設備市場規模預計2023年為94.7億美元，2024年達到104.6億美元，預計2030年將達到194.6億美元，複合年成長率為10.82%。

切片檢查裝置專門用於診斷程序，提取細胞或組織樣本進行測試，以確定疾病的存在或程度。這些設備包括針頭、切片檢查引導系統、切片檢查鉗等。切片檢查設備在與疾病檢測和監測相關的多種醫療應用中發揮重要作用，包括乳房切片、胃腸道切片檢查、前列腺切片檢查、切片檢查和肺部切片檢查。全球癌症發生率的增加和對微創手術的偏好是推動市場成長的關鍵因素。相較之下，高昂的設備成本、與切片檢查程序相關的風險以及醫療當局嚴格的監管障礙正在阻礙市場成長。然而，多家供應商正在集中研究和開發努力來克服這些問題。此外，切片檢查設備製造流程的進步、切片檢查設備在研究和組織庫中的使用增加、醫療保健基礎設施的改善以及對新興國家的投資都有助於市場擴張。

主要市場統計
基準年[2023] 94.7億美元
預測年份 [2024] 104.6億美元
預測年份 [2030] 194.6億美元
複合年成長率（%） 10.82%

由於產品併發症的風險最小化，人們對針式切片檢查設備的偏好增加

切片檢查鉗是微創手術中使用的複雜手持式儀器，具有兩瓣結構。定位線可作為確定切片檢查正確部位的指南，尤其是在乳房切片過程中。它用於術前隔離乳房X光攝影或超音波中檢測到的不可觸及的病變，確保準確性並協助放射科醫生獲取組織標本。對於深部病變，首選針吸活體組織切片裝置，常見類型包括細針穿刺活體組織切片和粗針穿刺切片。眾所周知，這些儀器可以減少手術併發症並有效收集高品質樣本，有助於準確診斷。針式切片檢查裝置包括抽吸針、核心切片檢查裝置和真空輔助切片檢查裝置。抽吸針在細針抽吸切片檢查中發揮重要作用，細針抽吸活體組織切片用於檢查腫塊和腫塊。核心切片檢查裝置可取出小組織切片進行病理檢查，通常用於乳房、肝臟和骨骼切片檢查。真空輔助主題是微創切片檢查手術的高效工具。該裝置採用真空機制，可連續採集組織樣本，而無需重新插入針頭。手術托盤是一個緊湊、系統化的解決方案，適用於特定手術所需的所有切片檢查儀器。最佳化工作流程，促進資源高效利用，並提高程序無菌性。

技術MRI引導切片檢查在實現高診斷準確性的切片檢查設備中的重要作用

影像引導切片檢查是切片檢查設備領域的顯著創新，它利用了現代成像技術的精確度。這項先進技術使醫生能夠從難以進​​入的區域採集樣本，從而實現更精確、侵入性更小的手術。影像引導切片檢查包括MRI引導切片檢查、立體定位切片檢查和超音波引導切片檢查。 MRI 導引切片檢查已成為診斷難以到達區域或更複雜結構（例如大腦或乳房）異常的首選程序。立體定位切片檢查更容易應用於相對表面的異常，例如靠近乳房或皮膚的病灶。此手術的優點是確保患者準確診斷，同時避免侵入性手術帶來的不適。超音波引導切片檢查是頸部、胸部和腹部切片檢查的首選，主要是因為其具有提供即時影像的優勢。此外，超音波引導切片檢查具有成本效益，並且可以更快地進行切片檢查，這使得它們在成本和時間是主要考慮因素的情況下成為首選。相較之下，MRI引導切片檢查在晚期病例中處於領先地位，淺表病例需要立體定位切片檢查環，而超音波引導切片檢查具有即時性要求和成本效益，已被證明在多種情況下是有益的。非影像導引切片檢查涉及使用觸診和解剖標誌來確定切片檢查部位的技術，無需真實影像引導的幫助。影像切片檢查和非影像導引切片檢查之間的選擇很大程度上取決於病變的位置和性質、患者的健康狀況和可用資源。影像引導切片檢查在準確性和安全性方面具有廣闊的前景，特別是對於不可觸及的病變和深部病變。然而，對於表淺腫塊，非影像導引切片檢查仍然是一種快速且經濟高效的選擇。

應用 由於乳癌和攝護腺癌的癌症發生率不斷增加，對切片檢查設備的需求不斷增加

隨著世界各地乳癌患者數量的增加，對乳房切片檢查設備的需求也增加。真空輔助切片檢查(VAB) 系統等設備因其微創、可靠的診斷以及快速無痛的過程而越來越受歡迎。軟性乙狀結腸鏡是結腸切片檢查的首選，因為它們可以檢測直腸和乙狀結腸的異常情況。包括癌症在內的肺部疾病的盛行率不斷增加，引發了對切片檢查設備的需求，其中常用的是經胸針活體組織切片（TTNB）設備。對於攝護腺切片檢查，主要使用經直腸超音波（TRUS）引導的攝護腺切片檢查切片檢查裝置。隨著癌症發生率的增加，用於乳房和前列腺切片檢查的切片檢查裝置經歷了重大的技術進步。同時，用於切片檢查和結腸切片檢查的設備可用於多種疾病，包括癌症。切片檢查設備在醫學診斷中至關重要，反映了不斷進步並確保患者健康。

最終使用者：增加切片檢查設備的使用，以加快醫院的復健速度

學術和研究機構尋求創新的解決方案來提高切片檢查程序的準確性和效率，特別關注非侵入性程序。這些研究機構正在尋求先進、先進的切片檢查設備，以開拓醫學研究的新領域。診斷中心和影像診斷中心著重及時、準確的診斷。這些設施需要切片檢查裝置，以最大限度地減少患者的不適並允許快速採集樣本。切片檢查設備可實現更短的恢復時間、更少的併發症和更低的成本，是主要關注患者安全、舒適和成本效益的初級醫療保健提供者和醫院的理想選擇。這些使用者群體的通用目標是提高切片檢查程序的準確性和效率。不同的產業需要推動市場發展，帶來更細緻的創新並改善全球健康。

區域洞察

在美洲，由於各種癌症患者的增加，切片檢查設備的使用正在增加。根據美國癌症協會估計，2023 年將有 1,958,310 例新癌症病例。這與切片檢查設備的需求直接相關。最尖端科技和醫療進步以及該地區有利的報銷政策正在促進市場成長。此外，人們對癌症早期檢測的認知不斷提高，再加上強力的醫療保健行銷，這為該地區切片檢查設備的更多使用鋪平了道路。此外，歐洲、中東和非洲地區對切片檢查設備的需求很高，該地區的特點是人口迅速老化和癌症發病率高。技術先進的醫療設備和基礎設施的引進也推動了市場的湧入。該地區的國家醫療保健系統促進了及時、準確的癌症診斷，並擴大了切片檢查設備的使用範圍。世界衛生組織 (WHO) 和歐洲腫瘤研究所進行的宣傳宣傳活動刺激了該地區對切片檢查設備的需求。此外，包括癌症文明病在亞太地區正在迅速增加。人口老化、環境污染和不健康的生活方式正在增加癌症的發生率，並增加對切片檢查設備的需求。此外，醫療保健系統的改善、醫療成本的上升以及對早期癌症檢測的認知的提高也是推動切片檢查設備採用的因素。

FPNV定位矩陣

FPNV 定位矩陣對於評估切片檢查設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對切片檢查設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.切片檢查設備市場的市場規模和預測是多少？

2.在切片檢查設備市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.切片檢查設備市場的技術趨勢和法規結構是什麼？

4.切片檢查設備市場主要供應商的市場佔有率是多少？

5. 進入切片檢查設備市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和胃腸道疾病的發生率增加
      • 更多採用微創技術
      • 提高人們對早期疾病檢測和篩檢重要性的認知
    • 抑制因素
      • 生產切片檢查裝置的成本很高。
    • 機會
      • 切片檢查設備的持續技術進步
      • 液體切片檢查設備的成長趨勢
    • 任務
      • 衛生當局嚴格監管的問題
  • 市場區隔分析
    • 產品：由於併發症風險最小，人們越來越偏好針式切片檢查裝置。
    • 技術：MRI引導切片檢查在切片檢查設備中發揮重要作用，以實現高診斷準確性
    • 用途：由於乳癌和攝護腺癌病例的增加，對乳癌和攝護腺癌的需求也在增加。
    • 最終用戶：提高切片檢查設備的利用率，以加快醫院的恢復速度
  • 市場趨勢分析
    • 再加上美洲大公司的強大影響力，開發新型切片檢查設備的研究活動正在增加。
    • 由於區域監管機構的產品核可增加以及研發活動的擴大，亞太地區切片檢查設備的應用不斷擴大
    • 歐洲、中東和非洲地區先進的醫療設施以及癌症檢測和預防計劃
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章切片檢查設備市場：依產品

  • 切片檢查鉗
  • 定位線
  • 針切片檢查儀器
  • 治療托盤

第7章切片檢查設備市場：依技術分類

  • 影像引導切片檢查
  • 非影像引導切片檢查

第8章切片檢查設備市場：按應用

  • 骨髓切片檢查
  • 乳房切片
  • 切片檢查
  • 切片檢查
  • 攝護腺切片檢查

第 9 章切片檢查設備市場：按最終用戶分類

  • 學術研究所
  • 診斷/影像診斷中心
  • 醫院

第10章美洲切片檢查設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太切片檢查設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲切片檢查設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • LUMINELLE宣布中國國家智慧財產局決定授予LUMINELLE Bx（切片檢查）系統專利，擴大全球擴張
    • Limaca Medical 突破性精密胃腸內切片檢查設備獲得 FDA 510(k) 許可
    • 史賽克 (Stryker) 宣布推出具有顱腦引導軟體的 Q 引導系統
    • Merit Medical 收購 Angiodynamics 導管產品組合和切片檢查系統
    • Argon SuperCore Advantage切片檢查設備在美國推出
    • Quest Diagnostics 收購 Haystack Oncology，將敏感液態生物檢體技術添加到其腫瘤產品組合中，以改善個人化癌症治療
    • Innovia Medical 在 BACO International 2023 上推出口腔旋轉切片檢查打孔器
    • Guardant360 CDx 獲得 FDA核准作為 ORSERDU 的伴同性診斷
    • TransMed7 LLC 宣布 SpeedBird 乳房切片檢查設備在商業發布前首次臨床使用
    • Terumo Corporation India 與 Argon Medical 合作擴大產品組合

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4103B31E073F

[183 Pages Report] The Biopsy Devices Market size was estimated at USD 9.47 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 10.82% to reach USD 19.46 billion by 2030.

The biopsy devices are used explicitly in diagnostic procedures that involve the extraction of sample cells and tissues for examination aimed at identifying the existence and extent of a disease. These devices range from needle biopsy devices, biopsy guidance systems to biopsy forceps. Biopsy devices have a crucial role in several medical applications pertaining to disease detection and monitoring, including breast biopsy, gastrointestinal biopsy, prostate biopsy, liver biopsy, and lung biopsy. An increasing prevalence of cancer worldwide and a growing preference for minimally invasive surgeries are pivotal factors driving the market growth. In contrast, high equipment costs, risks associated with biopsy procedures, and the stringent regulatory hurdles by health authorities hinder the market growth. However, several vendors are focusing on R&D to overcome these issues. Furthermore, advancements in the manufacturing process of biopsy devices, extending the usage of biopsy devices in research and tissue banking, improved healthcare infrastructures, and investments in emerging economies contribute to market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 9.47 billion
Estimated Year [2024] USD 10.46 billion
Forecast Year [2030] USD 19.46 billion
CAGR (%) 10.82%

Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications

Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.

Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy

Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient's health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.

Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas

The upsurge in breast cancer cases worldwide has subsequently triggered the need for breast biopsy devices. Devices such as vacuum-assisted biopsy (VAB) systems attain favor for their minimally invasive nature, confident diagnosis, and high-speed, painless process. Flexible sigmoidoscopes are preferred for colorectal biopsy due to their ability to detect abnormalities in the rectum and sigmoid colon. The rising incidence of lung conditions, including cancer, triggers the need for lung biopsy devices, where transthoracic needle biopsy (TTNB) devices are commonly used. Prostate biopsy procedures largely use transrectal ultrasound (TRUS) guided prostate biopsy devices, as per need-based preference. Biopsy devices for breast and prostate biopsies are undergoing significant technological advancement owing to rising cancer rates. Simultaneously, devices for lung and colorectal biopsies address a range of illnesses, cancer included. Biopsy devices remain paramount in medical diagnosis, reflecting continuous progress and ensuring patient health.

End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals

Academic and research institutes pursue innovative solutions for improving the accuracy and efficiency of biopsy procedures, with a particular emphasis on non-invasive techniques. These institutions seek sophisticated and advanced biopsy devices that allow them to explore new frontiers of medical research. Diagnostic and imaging centers focus primarily on timely and accurate diagnosis. They require biopsy devices that facilitate rapid sample collection with minimal patient discomfort. Biopsy devices that allow for shorter recovery times, fewer complications, and lower costs are ideally preferred by primary healthcare providers and hospitals as they mainly focus on patient safety, comfort, and cost-effectiveness. The shared objective across these user groups is to enhance biopsy procedure accuracy and efficiency. The varied sector needs to drive market evolution, promising more subtle innovations and improved global health outcomes.

Regional Insights

The Americas region has witnessed a rising trend in the utilization of biopsy devices due to the increase in various cancer cases. According to the American Cancer Society, in 2023, there are estimated to be 1,958,310 new cancer cases. This directly contributes to the need for biopsy devices. State-of-the-art technology and medical advancements, alongside favorable reimbursement policies in this region, contribute to the market growth. Also, growing awareness about early detection of cancer, reinforced by strong healthcare marketing, paves the path for increased use of biopsy devices in the region. Furthermore, the EMEA region, characterized by rapidly aging populations and a high incidence of cancer, has a strong need for biopsy devices. The market inflow is also credited to the adoption of technologically advanced healthcare equipment and infrastructure. National healthcare systems in this region promote timely and accurate cancer diagnosis, enabling increased biopsy device utilization. The awareness campaigns by the World Health Organization (WHO) and the European Institute of Oncology stimulate the need for biopsy devices in the region. Moreover, the APAC region is experiencing a rapid increase in lifestyle-related diseases, including cancers. The aging population, environmental pollution, and unhealthy lifestyle habits are fueling the incidences of cancer, thereby increasing the need for biopsy devices. In addition, improving healthcare systems, increasing healthcare spending, and raising awareness about early cancer detection are other factors fostering the adoption of biopsy devices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Biopsy Forceps
    • Localization Wires
    • Needle-Based Biopsy Instruments
      • Aspiration Needles
      • Core Biopsy Devices
      • Vacuum-Assisted Biopsy Devices
    • Procedure Trays
  • Technique
    • Image Guided Biopsy
      • MRI-Guided Biopsy
      • Stereotactic-Guided Biopsy
      • Ultrasound-Guided Biopsy
    • Non-Image Guided Biopsy
  • Application
    • Bone Marrow Biopsy
    • Breast Biopsy
    • Kidney Biopsy
    • Lung Biopsy
    • Prostate Biopsy
  • End User
    • Academic & Research Institutes
    • Diagnostic & Imaging Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopsy Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Devices Market?

3. What are the technology trends and regulatory frameworks in the Biopsy Devices Market?

4. What is the market share of the leading vendors in the Biopsy Devices Market?

5. Which modes and strategic moves are suitable for entering the Biopsy Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
      • 5.1.1.2. Rise in adoption of minimally-invasive techniques
      • 5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of biopsy devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous technological advancements in biopsy devices
      • 5.1.3.2. Growing inclination towards liquid biopsy devices
    • 5.1.4. Challenges
      • 5.1.4.1. Problems associated with stringent regulations by health authorities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
    • 5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
    • 5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
    • 5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
  • 5.3. Market Trend Analysis
    • 5.3.1. Growing research activities in developing novel biopsy devices coupled with robust presence of major companies in the Americas region
    • 5.3.2. Increasing product approvals from regional regulatory bodies coupled with growing research and development activities to expand the application of biopsy devices in the APAC region
    • 5.3.3. Advanced healthcare facilities and cancer detection and prevention program in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Biopsy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Biopsy Forceps
  • 6.3. Localization Wires
  • 6.4. Needle-Based Biopsy Instruments
  • 6.5. Procedure Trays

7. Biopsy Devices Market, by Technique

  • 7.1. Introduction
  • 7.2. Image Guided Biopsy
  • 7.3. Non-Image Guided Biopsy

8. Biopsy Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Bone Marrow Biopsy
  • 8.3. Breast Biopsy
  • 8.4. Kidney Biopsy
  • 8.5. Lung Biopsy
  • 8.6. Prostate Biopsy

9. Biopsy Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Diagnostic & Imaging Centers
  • 9.4. Hospitals

10. Americas Biopsy Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biopsy Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biopsy Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
    • 13.3.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
    • 13.3.3. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
    • 13.3.4. Merit Medical Acquires AngioDynamics' Catheter Portfolio and Biopsy System
    • 13.3.5. Argon's SuperCore Advantage Biopsy Instrument Launched in United States
    • 13.3.6. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
    • 13.3.7. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
    • 13.3.8. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
    • 13.3.9. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
    • 13.3.10. Terumo India Partners with Argon Medical to Expand Portfolio

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOPSY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPSY DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. GERM